Compare CNH & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNH | ASND |
|---|---|---|
| Founded | 1842 | 2006 |
| Country | United Kingdom | Denmark |
| Employees | 34197 | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6B | 13.6B |
| IPO Year | N/A | 2014 |
| Metric | CNH | ASND |
|---|---|---|
| Price | $11.53 | $239.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 16 |
| Target Price | $13.46 | ★ $279.50 |
| AVG Volume (30 Days) | ★ 17.2M | 458.1K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.86% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $97.60 |
| Revenue Next Year | $8.50 | $43.64 |
| P/E Ratio | $31.00 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.00 | $150.99 |
| 52 Week High | $13.87 | $248.60 |
| Indicator | CNH | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 57.33 | 60.38 |
| Support Level | $10.69 | $190.49 |
| Resistance Level | $13.22 | $248.60 |
| Average True Range (ATR) | 0.41 | 9.44 |
| MACD | 0.14 | 1.98 |
| Stochastic Oscillator | 86.06 | 79.64 |
CNH Industrial is the world's second largest manufacturer of agricultural machinery (82% of industrial net sales) as well as a major player in construction equipment (18% of industrial net sales). Its Case and New Holland brands have served farmers for generations. Geographically, agriculture sales are 40% North America, 32% Europe, Middle East, and Africa, 18% South America, and 10% Asia-Pacific. CNH's products are available through a robust independent dealer network, which includes over 2,600 dealer and distribution locations and reach into 164 countries. The construction business leverages over 400 dealers. The company's captive finance arm provides retail financing to its customers as well as wholesale financing for dealers to maintain inventory, which supports sales.
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.